# Octapharma Plasma Inc – FDA Inspection, Aug 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/327e2182-c196-4413-8c1d-1016605503ff
Source feed: FDA_Inspections

> FDA inspection 1220244 of Octapharma Plasma Inc, August 15, 2023. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220244
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-08-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1061286 - 2018-08-02

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dylan-r-jock/a083cb5e-95d7-491d-9c6d-8c36c5963ddf)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/e193cef3-8ece-43bb-842f-06bdfb355317

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d